{"id":"https://openalex.org/W7225179072","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0009","title":"9 The B-NDG hCRBN humanized mouse model enables in vivo evaluation of CRBN-based targeted protein degraders and molecular glue therapeutics","display_name":"9 The B-NDG hCRBN humanized mouse model enables in vivo evaluation of CRBN-based targeted protein degraders and molecular glue therapeutics","alternate_titles":[],"publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225179072","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0009"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0009","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0009","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0009","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A10.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"parent_works":[],"lineage":["https://openalex.org/W7225179072"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A10.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100333639","display_name":"Yue Zhang","orcid":"https://orcid.org/0000-0001-6153-9833","observed_orcids":["https://orcid.org/0000-0001-6153-9833"]},"institutions":[{"id":"https://openalex.org/I4210099020","display_name":"Beijing Biocytogen (China)","ror":"https://ror.org/01spyyb53","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210099020"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yue Zhang","raw_affiliation_strings":["Biocytogen Pharmaceuticals, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocytogen Pharmaceuticals, Beijing, China","institution_ids":["https://openalex.org/I4210099020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125613322","display_name":"Xiaofei Zhou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099020","display_name":"Beijing Biocytogen (China)","ror":"https://ror.org/01spyyb53","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210099020"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaofei Zhou","raw_affiliation_strings":["Biocytogen Pharmaceuticals, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocytogen Pharmaceuticals, Beijing, China","institution_ids":["https://openalex.org/I4210099020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5144049099","display_name":"Ying Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099020","display_name":"Beijing Biocytogen (China)","ror":"https://ror.org/01spyyb53","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210099020"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ying Zhao","raw_affiliation_strings":["Biocytogen Pharmaceuticals, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocytogen Pharmaceuticals, Beijing, China","institution_ids":["https://openalex.org/I4210099020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160473309","display_name":"Yuanyuan Zhou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099020","display_name":"Beijing Biocytogen (China)","ror":"https://ror.org/01spyyb53","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210099020"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuanyuan Zhou","raw_affiliation_strings":["Biocytogen Pharmaceuticals, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocytogen Pharmaceuticals, Beijing, China","institution_ids":["https://openalex.org/I4210099020"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100611356","display_name":"Jay Zhang","orcid":"https://orcid.org/0009-0008-4389-4901","observed_orcids":["https://orcid.org/0009-0008-4389-4901"]},"institutions":[{"id":"https://openalex.org/I4210099020","display_name":"Beijing Biocytogen (China)","ror":"https://ror.org/01spyyb53","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210099020"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jay Zhang","raw_affiliation_strings":["Biocytogen Pharmaceuticals, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocytogen Pharmaceuticals, Beijing, China","institution_ids":["https://openalex.org/I4210099020"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210099020"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A10","last_page":"A10"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cereblon","display_name":"cereblon","score":0.7789999842643738},{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.8479999899864197},{"id":"https://openalex.org/keywords/protacs","display_name":"PROTACs","score":0.7889999747276306},{"id":"https://openalex.org/keywords/targeted-protein-degraders","display_name":"targeted protein degraders","score":0.8849999904632568},{"id":"https://openalex.org/keywords/molecular-glue-degraders","display_name":"molecular glues","score":0.9049999713897705},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cereblon-e3-ligase-modulator","display_name":"cereblon E3 ligase modulator","score":0.8960000276565552},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6899999976158142},{"id":"https://openalex.org/keywords/ubiquitin-proteasome-system","display_name":"ubiquitin-proteasome system","score":0.7630000114440918}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7703999876976013},{"id":"https://openalex.org/C2776156784","wikidata":"https://www.wikidata.org/wiki/Q3491954","display_name":"Humanized mouse","level":3,"score":0.6747000217437744},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.43959999084472656},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4327999949455261},{"id":"https://openalex.org/C2779937294","wikidata":"https://www.wikidata.org/wiki/Q5513666","display_name":"GLUE","level":2,"score":0.42660000920295715},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38269999623298645},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3801000118255615},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3095000088214874},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.30630001425743103},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28040000796318054},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26820001006126404}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0009","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0009","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0009","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A10.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:a77b4eb5140648afb1e58ca87389cbfb","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/a77b4eb5140648afb1e58ca87389cbfb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 14, Iss Suppl 2 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0009","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0009","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0009","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A10.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225179072.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409630317","https://openalex.org/W7148925553","https://openalex.org/W4409637248","https://openalex.org/W4411545489","https://openalex.org/W4403749056","https://openalex.org/W4308402776","https://openalex.org/W7223166680","https://openalex.org/W7154970641","https://openalex.org/W2902431667","https://openalex.org/W4391050560"],"abstract_inverted_index":{"Background":[0],"Cereblon":[1],"(CRBN)":[2],"is":[3],"a":[4,34,99,249,272],"substrate":[5],"receptor":[6],"of":[7,16,28,63,71,81,126,134,187,212,282],"the":[8,38,61,72,79,109,122,127,175,184,188,190,199,259],"CRL4^CRBN":[9],"E3":[10,76,86],"ubiquitin":[11],"ligase":[12,87],"complex,":[13],"which":[14],"consists":[15],"CRBN,":[17],"DNA":[18],"damage-binding":[19],"protein":[20,169],"1":[21,30,213],"(DDB1),":[22],"Cullin":[23],"4":[24],"(CUL4),":[25],"and":[26,45,49,93,180,214,240,270,279,289],"regulator":[27],"Cullins":[29],"(ROC1).":[31],"CRBN":[32,66,129,136,148,168,268],"plays":[33],"critical":[35],"role":[36],"in":[37,60,153,171,198,217,274],"ubiquitin-proteasome":[39],"system":[40],"by":[41,115],"recognizing":[42],"specific":[43],"substrates":[44],"mediating":[46],"their":[47],"ubiquitination":[48],"subsequent":[50],"proteasomal":[51],"degradation.":[52],"Due":[53],"to":[54,57,254],"its":[55],"ability":[56],"recruit":[58],"neosubstrates":[59],"presence":[62],"CRBN-binding":[64],"compounds,":[65],"has":[67],"emerged":[68],"as":[69,242,244],"one":[70],"most":[73],"widely":[74],"utilized":[75],"ligases":[77],"for":[78,102,277],"development":[80],"immunomodulatory":[82],"drugs":[83],"(IMiDs),":[84],"cereblon":[85],"modulators":[88],"(CELMoDs),":[89],"molecular":[90,286],"glue":[91,287],"degraders,":[92,288],"proteolysis-targeting":[94],"chimeras":[95],"(PROTACs).Methods":[96],"To":[97,182],"establish":[98],"preclinical":[100],"platform":[101,276],"evaluating":[103],"human":[104,128,135,147,201,267],"CRBN-targeting":[105,255],"therapeutics,":[106],"Biocytogen":[107],"generated":[108],"B-NDG":[110,155,218,224,226,260],"hCRBN":[111,156,219,227,261],"humanized":[112,262],"mouse":[113,117,140,159,263],"model":[114,264],"replacing":[116],"Crbn":[118,141,160],"exons":[119],"2\u20133":[120],"with":[121,222],"coding":[123],"sequence":[124],"(CDS)":[125],"gene,":[130],"enabling":[131],"exclusive":[132],"expression":[133,170,269],"while":[137],"eliminating":[138],"endogenous":[139],"expression.":[142],"RT-PCR":[143],"analysis":[144,166],"demonstrated":[145],"that":[146],"mRNA":[149],"was":[150,196],"specifically":[151],"detected":[152],"homozygous":[154],"mice,":[157,225],"whereas":[158],"transcripts":[161],"were":[162],"absent.":[163],"Western":[164],"blot":[165],"confirmed":[167],"multiple":[172],"tissues,":[173],"including":[174,234],"lung,":[176],"liver,":[177],"kidney,":[178],"spleen,":[179],"heart.Results":[181],"evaluate":[183],"translational":[185],"utility":[186],"model,":[189],"CRBN-based":[191,283],"PROTAC":[192,290],"compound":[193],"QCA-570":[194,205],"(dBET6)":[195],"tested":[197],"MV-4-11":[200],"leukemia":[202],"xenograft":[203],"model.":[204],"induced":[206],"significant":[207],"tumor":[208,246],"regression":[209],"at":[210],"doses":[211],"2.5":[215],"mg/kg":[216],"mice.":[220],"Compared":[221],"wild-type":[223],"mice":[228],"exhibited":[229],"more":[230,250],"pronounced":[231],"drug-associated":[232],"toxicity,":[233],"body":[235],"weight":[236],"loss,":[237],"reduced":[238],"activity,":[239],"mortality,":[241],"well":[243],"delayed":[245],"regrowth,":[247],"suggesting":[248],"human-relevant":[251],"pharmacological":[252],"response":[253],"degraders.Conclusions":[256],"In":[257],"summary,":[258],"successfully":[265],"recapitulates":[266],"provides":[271],"valuable":[273],"vivo":[275],"efficacy":[278],"safety":[280],"evaluation":[281],"small":[284],"molecules,":[285],"therapeutics.":[291]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7225179072","counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-04T00:00:00"}
